Knocking down 10-formyltetrahydrofolate dehydrogenase increased oxidative stress and impeded zebrafish embryogenesis by obstructing morphogenetic movement |
| |
Authors: | Wen-Ni Chang Gang-Hui Lee Tseng-Ting Kao Cha-Ying Lin Tsun-Hsien Hsiao Jen-Ning Tsai Bing-Hung Chen Yau-Hung Chen Hsin-Ru Wu Huai-Jen Tsai Tzu-Fun Fu |
| |
Affiliation: | 1. Institute of Basic Medical Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan;2. Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan;3. School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 402, Taiwan;4. Department of Biotechnology, Kaohsiung Medical University, Kao;hsiung 807, Taiwan;5. Department of Chemistry, Tamkang University, Taipei 106, Taiwan;6. Institute of Molecular and Cellular Biology, National Taiwan University, Taipei 106, Taiwan |
| |
Abstract: | BackgroundFolate is an essential nutrient for cell survival and embryogenesis. 10-Formyltetrahydrofolate dehydrogenase (FDH) is the most abundant folate enzyme in folate-mediated one-carbon metabolism. 10-Formyltetrahydrofolate dehydrogenase converts 10-formyltetrahydrofolate to tetrahydrofolate and CO2, the only pathway responsible for formate oxidation in methanol intoxication. 10-Formyltetrahydrofolate dehydrogenase has been considered a potential chemotherapeutic target because it was down-regulated in cancer cells. However, the normal physiological significance of 10-Formyltetrahydrofolate dehydrogenase is not completely understood, hampering the development of therapeutic drug/regimen targeting 10-Formyltetrahydrofolate dehydrogenase.Methods10-Formyltetrahydrofolate dehydrogenase expression in zebrafish embryos was knocked-down using morpholino oligonucleotides. The morphological and biochemical characteristics of fdh morphants were examined using specific dye staining and whole-mount in-situ hybridization. Embryonic folate contents were determined by HPLC.ResultsThe expression of 10-formyltetrahydrofolate dehydrogenase was consistent in whole embryos during early embryogenesis and became tissue-specific in later stages. Knocking-down fdh impeded morphogenetic movement and caused incorrect cardiac positioning, defective hematopoiesis, notochordmalformation and ultimate death of morphants. Obstructed F-actin polymerization and delayed epiboly were observed in fdh morphants. These abnormalities were reversed either by adding tetrahydrofolate or antioxidant or by co-injecting the mRNA encoding 10-formyltetrahydrofolate dehydrogenase N-terminal domain, supporting the anti-oxidative activity of 10-formyltetrahydrofolate dehydrogenase and the in vivo function of tetrahydrofolate conservation for 10-formyltetrahydrofolate dehydrogenase N-terminal domain.Conclusions10-Formyltetrahydrofolate dehydrogenase functioned in conserving the unstable tetrahydrofolate and contributing to the intracellular anti-oxidative capacity of embryos, which was crucial in promoting proper cell migration during embryogenesis.General significanceThese newly reported tetrahydrofolate conserving and anti-oxidative activities of 10-formyltetrahydrofolate dehydrogenase shall be important for unraveling 10-formyltetrahydrofolate dehydrogenase biological significance and the drug development targeting 10-formyltetrahydrofolate dehydrogenase. |
| |
Keywords: | FDH, 10-formyltetrahydrofolate dehydrogenase THF, tetrahydrofolate dpf, day-post-fertilization hpf, hour-post-fertilization MO, morpholino oligonucleotide WISH, whole-mount in situ hybridization FDH-N-ter, FDH N-terminal domain |
本文献已被 ScienceDirect 等数据库收录! |
|